Naomi Iwata Selected Research

Macrophage Activation Syndrome

5/2023	Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan.
1/2023	The dynamics of laboratory markers reflecting cytokine overproduction in macrophage activation syndrome complicated with systemic juvenile idiopathic arthritis.
1/2020	Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
1/2004	Inflammatory cytokines and systemic-onset juvenile idiopathic arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naomi Iwata Research Topics

Disease

19	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2023 - 01/2004
5	Fever (Fevers) 01/2023 - 01/2004
5	Infections 12/2021 - 09/2013
4	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 12/2023 - 01/2020
4	Macrophage Activation Syndrome 05/2023 - 01/2004
4	Arthritis (Polyarthritis) 04/2019 - 01/2004
3	Ulcerative Colitis 07/2023 - 01/2023
3	Dermatomyositis (Dermatopolymyositis) 09/2019 - 12/2015
2	Autoimmune Diseases (Autoimmune Disease) 11/2019 - 10/2015
2	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2019 - 12/2015
2	Melanoma (Melanoma, Malignant) 12/2015 - 05/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024
1	Cryopyrin-Associated Periodic Syndromes 01/2024
1	COVID-19 related pediatric multisystem inflammatory disease 12/2023
1	Septic Shock (Toxic Shock Syndrome) 12/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2023
1	Pediatric ulcerative colitis 01/2023
1	Diarrhea 01/2023
1	Abdominal Pain (Pain, Abdominal) 01/2023
1	Skin Manifestations 01/2022
1	Body Weight (Weight, Body) 07/2021
1	Rheumatic Diseases (Rheumatism) 07/2021
1	Ulcer 01/2021
1	Pyoderma Gangrenosum 01/2021
1	Crohn Disease (Crohn's Disease) 10/2020
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 10/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2019
1	Uveitis 04/2019
1	Hypersensitivity (Allergy) 03/2019
1	Takayasu Arteritis (Arteritis, Takayasu's) 07/2018
1	Polyarteritis Nodosa (Periarteritis Nodosa) 07/2018
1	Localized Scleroderma (Morphea) 01/2017
1	Iridocyclitis 01/2017
1	Hepatitis B 05/2015
1	Tuberculosis (Tuberculoses) 05/2015
1	Virus Diseases (Viral Diseases) 09/2013
1	Leukopenia 09/2013
1	Human Influenza (Influenza) 09/2013
1	Inflammation (Inflammations) 09/2013
1	Rheumatoid Arthritis 08/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2012
1	Acute Retinal Necrosis Syndrome 09/2009
1	Necrosis 09/2009
1	Fibrosis (Cirrhosis) 06/2009
1	Serositis 01/2004
1	Exanthema (Rash) 01/2004
1	Disease Progression 01/2004
1	Systemic Scleroderma (Systemic Sclerosis) 10/2003

Drug/Important Bio-Agent (IBA)

9	tocilizumab (atlizumab)FDA Link 01/2020 - 03/2005
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 06/2009
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2004
3	canakinumab FDA Link 01/2024 - 01/2021
3	SteroidsIBA 07/2023 - 01/2004
3	CytokinesIBA 01/2023 - 01/2004
3	Adalimumab (Humira)FDA Link 03/2021 - 12/2012
3	Interleukin-6 (Interleukin 6)IBA 09/2013 - 01/2004
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2015
2	VaccinesIBA 07/2021 - 01/2020
2	Interleukin-18 (Interleukin 18)IBA 01/2021 - 05/2015
2	Infliximab (Remicade)FDA Link 01/2020 - 04/2019
2	AutoantibodiesIBA 09/2019 - 01/2017
2	C-Reactive ProteinIBA 04/2019 - 09/2013
2	AntibodiesIBA 04/2019 - 05/2015
2	Methotrexate (Mexate)FDA LinkGeneric 04/2019 - 08/2012
2	Monoclonal AntibodiesIBA 04/2014 - 02/2012
1	InterleukinsIBA 01/2024
1	Interleukin-1 (Interleukin 1)IBA 01/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023
1	vedolizumabIBA 07/2023
1	PalmitatesIBA 05/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2023
1	Calcineurin InhibitorsIBA 01/2023
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2023
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 07/2021
1	Ferritins (Ferritin)IBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2019
1	Abatacept (Orencia)FDA Link 04/2019
1	Ophthalmic Solutions (Eye Drops)IBA 04/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2018
1	LigandsIBA 12/2015
1	B-Cell Activating FactorIBA 12/2015
1	MicroRNAs (MicroRNA)IBA 10/2015
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 04/2014
1	Indicators and Reagents (Reagents)IBA 09/2013
1	Retinaldehyde (Retinal)IBA 09/2009
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2003

Therapy/Procedure

4	Therapeutics 12/2021 - 10/2003
1	Oral Administration 01/2023
1	Colectomy 01/2023
1	Heart-Assist Devices 12/2021
1	Artificial Respiration (Mechanical Ventilation) 12/2021
1	Enteral Nutrition (Feeding, Tube) 10/2020
1	Operative Surgical Procedures 07/2018